Furthermore, the endocannabinoid, AEA, reduced the growth of Mz-ChA-1-derived cholangiocarcinoma xenografts and downregulated the tumor expression of angiogenic factors, VEGF-C, VEGF-R2, and VEGF–R3 in AEA-treated tumors. This evidence concerns the gene VEGFA and neoplasm.